-
There Is No 'Gay Gene,' Major Study Concludes
drugs
August 30, 2019
There's no such thing as a single "gay gene" that drives a person's sexual behavior, concludes the largest genetic study ever conducted on the issue.
-
Atelerix Consortium Awarded £267,000 Innovate UK Grant for Collaboration with the Cell and Gene Therapy Catapult and Rexgenero on Cell Therapy Stabilisation Technologies
b3cnewswire
August 22, 2019
Rexgenero, a regenerative medicine company pioneering the development of advanced cell-based therapies to treat chronic limb-threatening ischaemia (CLI)...
-
Pfizer Invests $500M in Gene Therapy Facility
contractpharma
August 22, 2019
The Sanford, NC site to support continuing investment in gene therapy R&D .
-
U.S. Task Force Updates Breast Cancer Gene Testing Recommendations
drugs
August 21, 2019
Mutations in two genes -- BRCA1 and BRCA2 -- are known to significantly increase the risk of breast cancer, but experts have long debated which women should be tested for them.
-
Rozlytrek Approved to Treat Tumors With NTRK Gene Fusion
drugs
August 20, 2019
Rozlytrek (entrectinib), a kinase inhibitor, has received approval to treat adults and adolescents with cancer that carries the genetic defect neurotrophic tyrosine receptor kinase (NTRK) gene fusion and...
-
Scientists Creating Gene Map of Human 'Microbiome'
drugs
August 15, 2019
The number of genes in bacteria that live in and on people could top 1 billion trillion -- and at least half appear to be unique to their host.
-
Eurofins Genomics US Expands Gene Synthesis Capabilities
contractpharma
August 12, 2019
Acquires Blue Heron Biotech, known for expertise in gene synthesis and sub cloning ...
-
PTC Therapeutics Expands in New Jersey
contractpharma
August 06, 2019
Secures BMS biologics facility to support gene therapy production.
-
Trial Tests CRISPR Gene-Editing to Treat Sickle Cell Disease
drugs
August 01, 2019
A U.S. clinical trial of CRISPR gene-editing to treat people with sickle cell disease is underway.
-
Lonza, Vineti Enter Cell and Gene Therapy Network Alliance
contractpharma
July 31, 2019
Integrated offering includes logistics, scheduling, distribution, Chain of Condition, Chain of Custody, Chain of Identity, and Lonza’s MODA-ES.